Oculis Holding
OCS
OCS
57 hedge funds and large institutions have $535M invested in Oculis Holding in 2026 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.19% more ownership
Funds ownership: 34.51% → 34.71% (+0.19%)
0% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 11
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $13K
Holders
57
Holding in Top 10
6
Calls
–
Puts
$13K
Top Buyers
| 1 | +$23.8M | |
| 2 | +$22.1M | |
| 3 | +$11.4M | |
| 4 |
F
Folketrygdfondet
Oslo Norway,
Norway
|
+$3.62M |
| 5 |
HF
HRT Financial
New York
|
+$2.76M |
Top Sellers
| 1 | -$16.1M | |
| 2 | -$4.34M | |
| 3 | -$2.55M | |
| 4 |
PBM
Propel Bio Management
Los Angeles,
California
|
-$1.34M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$914K |
